Entyvio linked with lower serious infection risk in UC

Patients with ulcerative colitis treated with Entyvio had a lower risk for serious infections compared with those who received anti-TNF, according to study results.Siddharth Singh, MD, MS, from the University of California, San Diego, and colleagues wrote that with expanding options for inflammatory bowel disease treatment, there has been limited safety comparisons of therapies.“Tumor necrosis factor alpha have been associated with an increased risk of serious infections in clinical registries and real-world observational studies,” they wrote. “In contrast, [EntyvioRead More

Share on facebook
Share on twitter
Share on linkedin